Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 22, 2024Open Access

The splicing factor kinase SRPK1 is a therapeutic target for Peripheral Vascular Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

SBSohni Ria BhallaMWMussarat WahidJAJason Amartey

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bhalla et al. (2024) studied this question.

synapsesocial.com/papers/68e6e1f0b6db64358765dc8ahttps://doi.org/10.1101/2024.04.17.589996
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells2025 · 6 citations
  2. 2SRPK1 is a significant factor in driving the progression of diabetic kidney fibrosis2025 · 1 citations
  3. 3Endothelial SRSF1 regulates hematopoietic stem cell function in the bone marrow microenvironment2025
  4. 4Serine/Arginine-Protein Kinase 1 Co-Phosphorylation Signatures Uncover Splicing-Driven Mechanisms in Oncogenic Pathway Modulation2026
  5. 5SRPK3 exacerbates cardiac ischemia/reperfusion injury by regulating KLF3-mTOR/P70 S6K-mediated autophagy2026